Invenux, LLC

Fort Collins, CO

UEI
TE98A4TS48J1
CAGE
5N7X4
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
7982 Bayside Dr, Fort Collins, CO 80528, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Identification of the antisickling compounds in SCD-101 R43HL139173 National Heart Lung and Blood Institute (NIH) $224,731
Crossover study of an oral treatment for sickle cell disease R43HL137589 National Heart Lung and Blood Institute (NIH) $224,950
Elucidation of antisickling molecules in a botanical with antisickling activity R41AT008000 National Institutes of Health $397,926
First clinical trial of an anti-sickling botanical drug for sickle cell dise R43HL119086 National Institutes of Health $442,059
Safety studies for clinical trials of a botanical drug for sickle cell disease R44HL119086 National Heart Lung and Blood Institute (NIH) $1,499,750

Quick answers

Is Invenux, LLC registered in SAM.gov?

Yes. Invenux, LLC's SAM.gov registration is active through August 9, 2027.

What is Invenux, LLC's most recent federal award?

Invenux, LLC's most recent federal grant award is Identification of the antisickling compounds in SCD-101 (R43HL139173), from National Heart Lung and Blood Institute (NIH), on July 17, 2017.

On GovTribe

See Invenux, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login